AMETEK Inc. (AME) Falls 2.85% for February 05

Equities Staff |

One of the S&P 500’s big losers for Friday February 05 was AMETEK Inc. (AME). The company’s stock fell 2.85% to $45.31 on volume of 2.46 million shares.

The stock opened the day at 43.94 and traded between a low of $42.82 and a high of $45.95. The stock finished the day down $1.33 per share. AMETEK Inc. has an average daily volume of 1.51 million and a total float of 237.88 million shares. The 50-day SMA for AMETEK Inc. is $51.45 and its 200-day SMA is $53.37. The high for the stock over the last 52 weeks is $57.67 and the low is $44.69.

Ametek Inc is a manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America.

AMETEK Inc. is centered in Berwyn, PA, and has 15,400 employees. Today’s trading day leaves the company with a market cap of $10.78 billion. The company has a P/S ratio of n/a, P/B ratio of 3.25, and a 1649.8.

For a complete fundamental analysis analysis of AMETEK Inc., check out’s Stock Valuation Analysis report for AME. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…